In-house development of an optimized synthetic module for routine [(11)C]acetate production

[(11)C]Acetate, a radiotracer for PET imaging, is a promising radiopharmaceutical for overcoming the limitation of 2-deoxy-2-[(18)F]fluoro-d-glucose in a number of cancers. Here, the optimized automatic synthesis of [(11)C]acetate using an in-house-developed module under different conditions has been reported for routine production. [(11)C]CO(2) was produced in a 16.4 MeV PETtrace cyclotron, and methyl magnesium chloride was used for synthesis. For product purification, ion-exchange solid-phase extraction cartridges were used, connected in series. High-performance liquid chromatography and gas chromatography were used to measure radiochemical and chemical purity. The Limulus amebocyte lysate test and the fluid thioglycollate medium test were performed for quality control of [(11)C]acetate. The total reaction time of [(11)C]acetate was within 15 min, and the overall decay-corrected radiochemical yield was 84.33±8.85%. Radiochemical purity was greater than 98% when evaluated on an analytical high-performance liquid chromatography system. No endotoxins or anaerobic bacteria were seen on quality control checks. Optimized production of [(11)C]acetate was achieved by the in-house module. Radiochemical and biological properties of the [(11)C]acetate produced were appropriate for clinical PET study.